Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Weidong Xiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3266-6440; OpenAlex author ID A5053954336. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 4 papers · 2024: 2 papers

Papers 12

  1. LINC02086 inhibits ferroptosis and promotes malignant phenotypes of pancreatic cancer via miR-342-3p/CA9 axis. Last author DOI 10.1007/s10142-024-01329-8↗
  2. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer. Last author DOI 10.1016/j.gene.2023.148078↗
  3. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma. Co-author DOI 10.1007/s00464-022-09441-1↗
  4. Establishment of a novel signature to predict prognosis and immune characteristics of pancreatic cancer based on necroptosis-related long non-coding RNA. Last author DOI 10.1007/s11033-023-08663-3↗
  5. Distribution characteristics and clinical significance of infiltrating T cells in the tumor microenvironment of pancreatic cancer. Last author DOI 10.3892/ol.2023.13847↗
  6. [Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑cat… Last author DOI 10.3892/or.2023.8493↗
  7. Hsa_circ_0046523 Mediates an Immunosuppressive Tumor Microenvironment by Regulating MiR-148a-3p/PD-L1 Axis in Pancreatic Cancer. Last author DOI 10.3389/fonc.2022.877376↗
  8. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer. Last author DOI 10.1111/jcmm.15900↗
  9. Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis Co-author DOI 10.21203/rs.3.rs-86053/v1↗
  10. Long-Term Oncological Outcomes in Laparoscopic Versus Open Pancreaticoduodenectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.1089/lap.2018.0683↗
  11. The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer. Last author DOI 10.3892/or.2018.6700↗
  12. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signali… Last author DOI 10.3892/or.2017.5705↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gen Sun · 6 shared papers, 2018–2024 · strength 0.98
  2. Yuanpeng Xiong · 4 shared papers, 2023–2024 · strength 0.86
  3. Wanpeng Xin · 3 shared papers, 2020–2024 · strength 0.58
  4. Long Peng · 4 shared papers, 2017–2023 · strength 0.47
  5. Xiaowei Fu · 3 shared papers, 2020–2022 · strength 0.40
  6. Jisheng Zhu · 1 shared paper, 2023 · strength 0.22
  7. Yong Li · 1 shared paper, 2023 · strength 0.22
  8. Le Hong · 2 shared papers, 2018–2020 · strength 0.20
  9. Yonghao Ouyang · 1 shared paper, 2023 · strength 0.18
  10. Yeqing Zou · 1 shared paper, 2020 · strength 0.13
  11. Bo Huang · 1 shared paper, 2020 · strength 0.13
  12. Xueqiang Deng · 1 shared paper, 2020 · strength 0.13
  13. Jiaqing Cao · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.